机译:甲状腺肿瘤的分子表型鉴定为分化型甲状腺癌诊断的标志物。
Department of Surgery St. Paul’s Hospital University of British Columbia C303-1081 Burrard Street Vancouver BC Canada V6Z-1Y6;
Department of Surgery St. Paul’s Hospital University of British Columbia C303-1081 Burrard Street Vancouver BC Canada V6Z-1Y6;
Department of Surgery St. Paul’s Hospital University of British Columbia C303-1081 Burrard Street Vancouver BC Canada V6Z-1Y6;
Department of Surgery St. Paul’s Hospital University of British Columbia C303-1081 Burrard Street Vancouver BC Canada V6Z-1Y6;
PhenoPath Laboratories Seattle WA USA;
Department of Pathology University of British Columbia Vancouver BC Canada;
Department of Medical Genetics British Columbia Cancer Agency Michael Smith Genome Sciences Center University of British Columbia Vancouver BC Canada;
Department of Medical Genetics British Columbia Cancer Agency Michael Smith Genome Sciences Center University of British Columbia Vancouver BC Canada;
Thyroid cancer; Molecular markers; Tissue microarray; Galectin-3;
机译:甲状腺肿瘤的分子表型鉴定了用于分化型甲状腺癌诊断的标记物组。
机译:甲状腺肿瘤的免疫表型鉴定可以识别分化为间变性癌的转化过程中改变的分子标记。
机译:下一代测序识别高度准确的miRNA面板,可区分良好分化的甲状腺癌与良性甲状腺结节
机译:放射性碘131消融甲状腺分化型甲状腺癌患者的临床工程和临床剂量
机译:肥胖与甲状腺癌风险和甲状腺功能标志物的关系
机译:2015年美国甲状腺协会关于甲状腺结节和分化型甲状腺癌的成年人在减少甲状腺癌的过度诊断和过度治疗中的重要性
机译:下一代测序识别高度准确的miRNA面板,可区分良好分化的甲状腺癌与良性甲状腺结节